Intra-Cellular Therapies Inc (NASDAQ:ITCI)

51.40
Delayed Data
As of Aug 19
 +0.66 / +1.30%
Today’s Change
28.45
Today|||52-Week Range
66.00
-1.80%
Year-to-Date

Today’s Trading

Previous close50.74
Today’s open50.17
Day’s range50.17 - 52.04
Volume30,666
Average volume (3 months)814,703
Market cap$5.1B
Data as of 4:00pm ET, 08/19/2022

Growth & Valuation

Earnings growth (last year)-8.39%
Earnings growth (this year)+8.49%
Earnings growth (next 5 years)+2.50%
Revenue growth (last year)+267.35%
P/E ratioNM
Price/Sales50.75
Price/Book10.50

Competitors

 Today’s
change
Today’s
% change
CYTKCytokinetics Inc-0.16-0.31%
EVOEvotec SE-0.30-2.24%
----
----
Data as of 3:59pm ET, 08/19/2022

Financials

Next reporting dateNovember 9, 2022
EPS forecast (this quarter)-$0.80
Annual revenue (last year)$83.8M
Annual profit (last year)-$284.1M
Net profit margin-339.04%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
New York, New York

Forecasts